Metabolic
- Active ingredient (INN)
- levocarnitine
- Composition (active ingredients)
- levocarnitine - 100,0 mg; 200,0 mg
- Фармакотерапевтическая группа
- metabolic agent
- Pharmacotherapeutic group
- solution for intravenous and intramuscular injection 100 mg/ml 5 ml №5; 200 mg/ml 5 ml №5
- Сonditions of supply
- on prescription
Indications
- as part of complex therapy for acute hypoxic conditions (acute cerebral hypoxia, ischemic stroke, transient ischemic attack). The drug is prescribed in the acute, subacute and recovery periods of cerebrovascular accidents
- with discirculatory encephalopathy and various traumatic and toxic brain lesions, in the recovery period after surgery
- with primary and secondary carnitine deficiency, including in patients with chronic renal failure on hemodialysis
- with cardiomyopathy, ischemic heart disease (angina pectoris, acute myocardial infarction, postinfarction conditions), hypoperfusion due to cardiogenic shock and other metabolic disorders in the myocardium
Dosage regimen
Levocarnitine is injected intravenously slowly or in a stream (2-3 minutes) or intramuscularly. Before intravenous administration, the contents of the ampoule are dissolved in 100-200 ml of solvent (0.9% sodium chloride solution or 5% dextrose (glucose) solution.
- For acute disorders of cerebral circulation
-
1 g/day (2 ampoules) for 3 days, and then 0,5 g/day (1 ampoule) for 7 days. After 10-12 days, repeated courses are possible within 3-5 days
- In the subacute and recovery period, with discirculatory encephalopathy and various brain lesions, carnitine deficiency
-
0,5-1 g/day (1-2 ampoules) intravenously (drip, jet) or intramuscularly (2-3 times a day) without dilution for 3-7 days. If necessary, a second course is prescribed after 12-14 days
- With secondary carnitine deficiency during hemodialysis
-
2 g (4 ampoules) once (after the procedure). Intravenous administration, slowly (2-3 min)
- In acute myocardial infarction, acute heart failure
-
3-5 g/day (6-10 ampoules), divided into 2-3 doses in the first 2-3 days, followed by a 2-fold dose reduction
- With cardiogenic shock
-
3-5 g/day (6-10 ampoules), divided into 2-3 doses until the patient comes out of shock. Then they switch to oral administration of levocarnitine
